1.Expression of lymphokine-1 and clinical significance of p53 protein mutation in hilar cholangiocarcinoma
Libin TIAN ; Haiguang ZHANG ; Chunling LIU
Clinical Medicine of China 2021;37(2):112-116
Objective:To analyze the expression and clinical significance of lymphoid enhancer factor-1 (LEF-1) and P53 protein in hilar cholangiocarcinoma.Methods:A total of 50 cases with hilarcholangiocarcinoma in the Tangshan People′s Hospital from March 2010 to December 2017 were retrospectively analyzed.P53 protein mutation was detected by immunohistochemistry.At the same time, the expression of LEF1 protein in cholangiocarcinoma and adjacent normal tissues was detected.The expression of LEF1 and its correlation with clinicopathological parameters were analyzed.At the same time, the relationship between p53 protein mutation and LEF1 protein expression and the prognosis of patients were discussed.Results:The positive expression rate of LEF1 in tumor tissues were 62.00%(31/50), which was higher than in adjacent tissues 36.00% (18/50). The difference was statistically significant (χ 2=6.763, P=0.016). There were 28 patients with TP53 protein mutation and 22 patients with wild type.The positive rate of LEF1 in TP53 mutant group was 75.00% (21/28), which was significantly higher than that in TP53 wild type group(45.45%, 10/22), and the difference was statistically significant(χ 2=4.565, P=0.03). The LEF1 expression was associated with tumor differentiation, TNM stage, lymph node metastasis and TP53 protein mutation (all P<0.05). LEF-1 expression was positively correlated with TP53 protein mutation ( r=0.294, P=0.04). The 1-year cumulative survival rate of patients with TP53 protein mutation was significantly lower than that of patients with TP53 protein wild type (60% vs.81%, P=0.0416). The 1-year cumulative survival rate of patients with LEF1 positive expression was also significantly lower than that of patients with negative expression (53% vs.82%, P=0.0180). Conclusion:LEF-1 is highly expressed in hilar cholangiocarcinoma, and patients with high expression have poor prognosis.The positive expression of LEF-1 in hilar cholangiocarcinoma patients with TP53 protein mutation was increased, and the prognosis of patients with TP53 protein mutation was poor.
2.The current status of Chinese medicine for the anti-myocardial ischemia and reperfusion ;injuryin oxidative stress profiles
Haiguang TIAN ; Chunjie MA ; Qiangwei HAO ; Hanbo ZENG ; Chao LI
International Journal of Traditional Chinese Medicine 2016;38(10):956-958
It’s said that a large number of oxygen free radicals in the ischemic region was one of the important pathogenesis of ischemia reperfusion injury. Based on the literature in recent years, this paper summarized the related researches on, the Chinese herbal medicine and the active components of anti myocardial ischemia reperfusion injury.
3.Effect of xinmailong on ischemic cardiac muscle during hemorrhagic shock
Kunlun TIAN ; Juan SU ; Haiguang FENG ; Rongxiang NUI
Chinese Journal of Pathophysiology 2001;17(8):787-
Xinmailong injection solution was invented at 1988 by prof. Li Shunan in Dali medical college. It was made from the material which has high biological activeness to the cardiac and vascular system. During the experimental shock caused by excessive loss of blood in monkey and dog, it was found by ECG that the T-wave of anterion lead on left chest elevated and became high and sharp after acute blood loss. Arterial blood pressure dropped to 8-5.3 kPa for dog and 8-5.3-2.7 kPa for monkey, changes of T-wave all recovered to near normal level after xinmailong solution was injected intravenously (0.05-0.2 mL/kg). These Results implied that xinmailong might improve the ischemia of myocardium induced by hemorrhagic shock.
4.Effects of Eerdun-Wurile on the Expressions of BDNF and NGF in the Prefrontal Cortex in Middle Cerebral Artery Occlusion / Reperfusion (MCAO / R) Injured Rats
Hua LIAN ; Chunjie MA ; Relebagen HU ; Chao LI ; Haiguang TIAN ; Zhibin XIAO
World Science and Technology-Modernization of Traditional Chinese Medicine 2016;18(7):1212-1218
The present study aimed to explore the effects of Eerdun-Wurile on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expressions in the prefrontal cortex of MCAO / R injury rats.Sixty SD male rats of SPF grade were selected to establish the model of MCAO / R with Zea-Longa thread occlusion,and divided into five groups at random:the sham operation group,the model group,the nimodipine group and the Eerdun-Wurile group.After modeling,rats were anesthetized for preparing the brains.The pathomorphological changes of the brains were evaluated by immunohistochemical techniques,such as HE staining and SP.The protein and mRNA expressions of BDNF and NGF in the prefrontal cortex of rats were detected by ELISA and RT-PCR,respectively.As a result,compared with the model group,it was found that the number of necrotic cells in the prefrontal cortex were significantly reduced in the Eerdun-Wurile group (P < 0.05),while the mRNA and protein expressions of BDNF and NGF were significantly increased (P < 0.05).In conclusion,the BDNF and NGF expressions in the prefrontal cortex were up-regulated for stimulating the activation of astrocytes and protecting the neurons with the treatment of Eerdun-Wurile in MCAO / R injured rats,which may be the mechanism of the treatment of Eerdun-Wurile for white vein disease.
5.Research progress of salvianolic acid A.
Li ZHANG ; Weiku ZHANG ; Ying ZHAO ; Xiuying YANG ; Lianhua FANG ; Shoubao WANG ; Lili SHI ; Xiaoyan YU ; Subo WANG ; Haiguang YANG ; Jialin SUN ; Shuo TIAN ; Guanhua DU
China Journal of Chinese Materia Medica 2011;36(19):2603-2609
Salvianolic acid A is a water-soluble component from Danshen, which is frequently used in traditional Chinese medicine. High performance liquid chromatography was often used to analyze content of salvianolic acid A. The yield of salvianolic acid A increased by the technological improvement of extraction and separation. Salvianolic acid A possessed multiple pharmacological activities, including antioxidants, myocardial ischemic protection, antithrombatic, neuroprotection, anti fibrosis, prevention of diabetes and complications. Recently, preliminary pharmacokinetics characteristics of salvianolic acid A were clarified. Based on the research literature and study work from author's laboratory, this review will focus on recent developments concerning the chemistry, pharmacology and pharmacokinetic of salvianolic acid A, and prospect further research.
Animals
;
Biomedical Research
;
Caffeic Acids
;
chemistry
;
isolation & purification
;
pharmacology
;
Drug Therapy
;
Drugs, Chinese Herbal
;
chemistry
;
isolation & purification
;
pharmacology
;
Humans
;
Lactates
;
chemistry
;
isolation & purification
;
pharmacology
;
Molecular Structure
;
Salvia miltiorrhiza
;
chemistry